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Exhibit Design and Construction Information
The goal of my visual thesis was to create an exhibit
for the lay person with the specific purpose of clarifying and
elucidating the impact that the loss of female hormone production
has on many organs of the body, and the implications this loss
has on quality of life for the individual. I also wanted to
include some simple anatomy and physiology lessons about hormone
synthesis and release.
I devoted a great deal of time to choosing, discarding,
rearranging, designing and redesigning my exhibit. Repeated
conferences with my advisors, Professor Wabnitz and Professor
Hintz were essential to the evolution of the exhibit design as
well as to the practical construction details. Several meetings
with Professor Thompson of the Industrial Design Department
proved invaluable as well, and in a few hours I felt I had
obtained a mini course in exhibit production and feasibility.
After a great deal of revision I produced five miniature
panels, 4 inches wide by 7 3/4 inches high. I finally achieved a
reduced scale finished product which was a faithful rendition of
the proposed exhibit. Drawings, color scheme and type size and
style had to be exactly right because I would be constructing the
actual panels at home. I would be on my own, with no
consultations with my advisors and no time to redo mistakes!
I decided to use 3/16 inch foam core board for
construction of the finished panels because although it is
fragile, it is very lightweight! After some practical
consideration such as measuring the cargo space of my station
wagon, I decided on a finished panel size of 32 inches wide by 72
inches tall. This made the size ratio of mock up to finished
piece 1 to 8, Therefor, 1 inch equaled 8 inches, 1/2 inch
equaled 4 inches, etc. Then it was easy to make a grid system
out of tracing paper to enlarge my small sketches to fit the
finished format. I also utilized enlarged xeroxed reproductions
of pre-existing drawings of the brain and vertebral column and
tailored them to my use - a big time saver!
To prepare the 3/16 inch foam board to accept paint
without warping, I brushed on three coats of Miniwax clear satin
finish polyurethane on the right sides of the background and cut
out pieces of foam core board, allowing drying time between
layers. I didn't find it necessary to apply polyurethane to the
undersides, as long as I did not paint them. After the
polyurethane dried, I used Mantrose Haeuser ready patch spackling
to finish all visible edges, and sanded them smooth after the
spackling had dried. Then I was ready to paint all pieces. I
used regular flat latex wall paint. It was inexpensive and
afforded me a huge color selection. I did find that even after
I had carefully selected my colors from the custom mix color
cards it was necessary to ask for small quantities of the base
colors in the mixes, as machine blended colors can vary from the
sample, and correction was needed. I also used acrylic paints
for some details.
I needed to reproduce several photographs in a greatly
enlarged dot pattern, which required that a negative be made of
my small photographs and a screen be used to produce the desired
effect. In dealing with production printers it was necessary to
be extremely specific about the finished product desired, even to
the degree of counting the dots per inch of the reproduction, and
what type of paper would be used. I learned to take nothing for
granted!
I used several brands of instant type, and I would
recommend planning well in advance exactly how many sheets of
what type of lettering are needed, because some brands of type
provide more of a specific letter than others. There is also a
big price difference between instant lettering brands.
As construction evolved, I used Elmers school glue to
bond the components of each panel together. After applying the
glue, I stacked heavy books on the panel to hold the pieces together
for several hours at least, and overnight if possible. I
attempted to complete each part of a panel before I glued the
portions of that panel together. This took careful planning,
especially in reference to applying the type correctly, but it
was worth it because it was much easier to work on small pieces
and then assemble them as a final step.
It was exciting to complete each step in the building
process and finally realize the goal I had worked for so long to
achieve!
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Loss of Female Hormones after Menopause:
Effects and Implications
In fact the role of women and the attitudes toward them
have changed more in the past hundred years than in the previous
thousand. 1
Changes - change of status, change of expectation,
change of life - women today are pioneers. The female student,
the young mother, the mature woman, and the elderly woman of
today are truly innovators, living in a time of revolutionary
upheaval , where there are no comforting traditions of
expectations and roles. They are unquestionably breaking new
ground.
For the student selecting courses and considering
vocations there is the realization that her choice will be a life
long career. In all probability it will not be preparation for a
stop gap job until marriage and motherhood intervene; it will not
be just a supplement to her husband's income; nor will it be an
"insurance policy"in case of widowhood. It will be for life.
The young mother of today no longer leaves the job world.
Chances are that she will remain in the workforce until
retirement age. The mature woman faces the challenge of making
health decisions at menopause which will help insure that her
longer life expectancy will be productively used and enjoyed.
The elderly woman is faced with her own set of choices. Never
before has medical technology created so many options for
advanced life support treatment. There may well be life and
1
Vern L. Bullough, The Subordinate Sex (Urbana: The Univerity
of Illinois Press, 1973, p. 342.
death choices which will be hers alone to make.
Women today must feel akin to the explorers of old,
setting out to discover new worlds with very few stars to guide
them! There is no authoritative evidence to count on - no
"bible" to live by. They are bombarded with a bewildering array
of conflicting advice. One expert proclaims that day care will
encourage sociability and independence in her child; another
insists that a mother must remain at home with her baby for at
least the first three years, or that child could be irreparably
damaged. Medical studies provide evidence that ingestion of
large amounts of calcium will prevent osteoporosis in
postmenopausal women. Then contrasting information is publicized
stressing that replacement estrogen must be given to prevent that
bone thinning disease. Coronary artery bypass surgery is
promoted to prevent heart attacks. Then further studies proclaim
that in most cases medication can produce the same results. Many
consumer advocate organizations are questioning the
appropriateness of employing artificial life support systems,
including tube feeding to prolong life at any cost, while other
groups caution that selective use of advanced technology sends us
down the slippery slope towards euthanasia.
How can women come to terms with the challenge of making
these new decisions? More and more in our better educated, more
consumer oriented and self accentuated society, we will face
the reality of becoming our own experts and the realization of
shouldering the burden of responsibility for the decisions we
make. After all, we can almost always cite at least one
scientific source somewhere to back up whatever position we wish
to take!
Consequently, in this thesis it is not sufficient to
solely present the facts on the effects of female hormone loss at
menopause as we currently know them. There is a plethora of
information already available on that subject. We must also
explore the larger questions of what we will do with this
information. What are our individual risks and benefits? How
can we work with our doctors as partners to obtain the most
accurate monitoring, and if needed, treatment for our hormone
loss before damage is done?
In the very near future we will become an older society.
It has been predicted that by the year 2030 the median age for
Americans will be 42 and the median age at death will be 84 - both
11 years higher than present day figures. Since our worker pool
will be aging, the trend toward early retirement will be
2
reversed, and we will be on the job longer. We cannot afford to
be robbed of our good health by diseases such as athrosclerosis
or osteoporosis. We will be needed longer at our posts to pay
into entitlement programs, plus there will not be enough younger
replacement workers available to allow us to retire until later.
These trends have ramifications for ourselves as well as
2
"Face of a Nation Growing
Older," Democrat and Chronicle, 12
December 1987, Sec. 3, p. 7
society- In order to understand and incorporate the basic
findings about hormone loss and confidently become information
gatherers, synthesizers, and utilizers we must assume a new role,
that of equal partner with our physician in assessing our present
health state, our future health risks, and what choices we will
make at the menopause time of life.
Since woman's life expectancy has jumped from a median
age of 44 years in 1887 to 79 years in 1987 and the average age
of menopause, 51 , has remained virutally the same during that
time period, it is easy to see that we now can count on spending
about one-third of our lives in a state of female hormone
deficiency. If or until evolution "catches up"it is our
responsibility to conscientiously monitor our own health status
including degree of hormone loss and how it is affecting the
organs of our body. We cannot afford any unpleasant
"surprises"
such as a broken hip or vertebral crush fractures that could have
been prevented.
Gone are the days when the doctor
'
s word was law - not
even to be questioned. Your life is the only one you have. It
3
is up to you to protect it and keep it healthy. Assertively
researching and sharing in the decision making burden with our
doctor is a new role for most women (and most doctors, too!). In
order to come to terms with our new responsibilities and have
confidence that we are equal to the task it is essential that we
3
Lewis Miller, The Life You Save (New York: William Morrow and
Co., Inc. 1979), p. 21
interpret our past - what has happened in this short one hundred
years. Our place in society has evolved so rapidly in such a
quick timespan than we need to understand where we have come from
in order to overcome our hesitancy about where we are going.
Prior to the late nineteenth century, fewer than 30% of
females reached the menopausal age of 51 years, today,
nearly 90% of women in the United States will experience
menopause -- 4
That nineteenth century female remained in the home -
her sanctuary, and also her isolation. Unless dire economic
necessity drove her out into the workplace, a woman's life
consisted of housework and family care.
5
In her book, Woman's Proper Place, Sheila Rothman
identifies four major shifts in definition of woman's place from
the post Civil War era to the present. Until 1900 the concept of
virtuous womanhood prevailed. Women gradually emerged from the
home, not to work, but to participate in womens groups such as
the Women's Christian Temperance Union (WCTU) and the Young
Woman's Christian Organization (YMCA). These groups initiated
social reforms and attempted to impose middle class morals on
lower classes - primarily immigrants. This stage led into the
concept of educated motherhood and the idea of university
training for young women. Public progams aimed at promoting the
health and welfare of women and children were beginning to
replace private charities, so women graduated to the next level of
development - woman as wife-companion, which was to begin in the
early 1 920
'
s and last through the 1950's, when the final concept,
woman as person evolved.
4
Herbert J. Buchsbaum, ed., The Menopause (New York: Springer-
Verlog, 1983), p. 23
5
Sheila M. Rothman, Woman's Proper Place (New York: Basic Books,
Inc., 1978)
The evolution of woman's maturation from virtuous
womanhood to woman as person advanced as a steady progression.
Certainly there were many women employed outside the home in
1900, but working was still only legitimate for a brief time
before marriage. It was essentially a temporary state -
certainly not a career!
Technology had freed the housewife from some of the
backbreaking labor involved in running a home and family, but did
not free her from the commitments and obligations of the home.
Now woman had time to care take and nurture outside the home. She
expanded her skills into the community with the origin of the
reform movement. Women's clubs were the school of the married
6
woman. They were a mutual improvement society as well as an
opportunity to bring about social improvement. Thus began
organized female fellowship. This antidote to the isolation
suffered by their mothers evolved into a powerful network of
Mothers' Clubs - the National Congress of Mothers which later
became the Parent Teachers Organization. Reform groups became
the vehicle for woman's suffrage since the right to vote was won,
not necessarily for equality, but to give women the power to
effectively influence legislation for the improvement of child
labor laws and other family reforms.
Educated motherhood became a way of integrating the
concept of university education with the future expectation of
motherhood. The number of women enrolled in colleges rose
6
Ibid. , p. 65
10
dramatically after Mathew Vassar proved that a college education
was not detrimental to a young girl's constitution. He devised a
regimen of structured physical activity interspersed with study
to counter warnings that excess mental strain would damage
women's health. Vassar and other women's colleges did provide
education for women, but did not encourage them to enter the
business or professional worlds. The number of college educated
women climbed from 85,000 in 1900 to 250,000 by 1920, but women
7
still represented only 10% of physicians and 2% of lawyers.
Coeds were offered a wide choice of social science courses, such
as Bryn Mawr ' s "Charities and Corrections." Many undergraduates
worked in settlement houses during vacations.
Women's social service coalitions were conducive in
pushing through the passage of the Sheppard-Towner Act by
congress in 1921. This, the first federally funded health care
program for women and children, was implemented by women
physicians, public health nurses, and social workers to provide
prenatal care and well baby checkups. This act was instrumental
in targeting the need for preventive medicine, which was soon
recognized by physicians as a service that should come under
their own professional auspices. By 1930 Sheppard-Towner was
repealed and the General Practitioner had shifted his practice
from the sickroom to the office to provide this care.
Many who discuss the Equal Rights Amendment struggle of
7
Ibid., p. 103
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the 1970s do not realize that this amendment was first bitterly
debated in the 1920s. The National Woman's Party pushed
vigorously for full social and economic equality for women, but
other factions of the suffrage coalition demanded protective
legislation for the female worker. Those for protection
prevailed, which was one factor in the tendancy for women to
remain in certain occupations such as teaching and office work.
As social reforms became more and more under government
control, women entered a new era and assumed a new role, that of
wife-companion. The revolutionary idea that woman's primary
concern should not be mother to her child but fascinating partner
to her husband was reflected in magazines, films of the day and
the rise of the cosmetic industry. Woman now had to assume
responsibility for keeping romance alive in marriage (a notion as
modern as Marabel Morgan's The Total Woman. ) "She still
8
remained as home, but she moved from the nursery to the
bedroom."
At the college level, sorority house living superceded the
settlement house dorm. One sorority objective was to train its
members to be ideal wives and hostesses (another idea that
persisted well into the 1950s, as the author can attest to!)
This new wife-companion was not a reformer, she was more private,
more self oriented. She was also interested in sex.
To Margaret Sanger, the concept of birth control (in the
form of a diaphragm) was a panacea for all the problems of the
8
Ibid., p. 177
12
lower classes. She urged women's organizations to strive for the
legalization of birth control devices as they had striven for
suffrage, but she was unsuccessful in her endeavor. Many
reformers would not publicly support birth control. They
believed a woman's role "...was not to emulate the bestial male
9
but to curb and refine him" - through lofty womanhood, not
contraceptives !
Just as well baby care came under the sole auspices of
doctors in the defeat of the Sheppard-Towner Act, so the original
concept of the trained lay person or nurse dispensing birth
control devices and information was unsuccessful and the duly
licensed physician became the only one legally able to prescribe
birth control (disease control). The middle class wife-companion
eagerly adopted birth control devices, but because of the lack of
public health clinic distribution, the lower classes were slow to
benefit from contraceptives - the very people Margaret Sanger had
targeted to help.
The ongoing development of the wife-companion was
interrupted by the depression and World War II. The federal
government began to fund day care centers in the 1930s - not to
free women for careers, but to employ out of work teachers. Day
care was still considered a last resort. This concept continued
through World War II, even though women were going to work in
unprecedented numbers. On one hand the government pleaded with
women to contribute to the war effort through jobs, popular
9
Ibid., p. 198
13
opinion and literature of the day still frowned upon working
mothers and chastised them for "parking" their children in day
care centers.
After the war, men quickly replaced women in
manufacturing jobs. "The war was not so much a transforming
experience as an interruption, after which women returned to
10
pursue an inherited role."
Now the post war building boom produced new suburbs and
new isolation for women. Between 1950 and 1960, the population
in 225 major cities rose 8.7% and their suburbs, 47%. These new
"bedroom communities"created a ghetto for women. Suburbia became
fertile ground for Betty Friedan's classic story based on her
1942 Smith classmates as seen 15 years after graduation. "is
1 1
this all?" was the plaintive question asked by those for whom
living through husband and children was not enough. That empty
feeling would persist until woman was able to choose a satisfying
career for herself.
Time saving household helpers such as freezers,
dishwashers, dryers, no frost refrigerators, garbage disposals,
self cleaning ovens, and no wax floors cut housework to a
minimum. These advances combined with many other factors, not
the lease of which was Enovid, the new
"miracle" birth control
10
Ibid., p. 224
11
Betty Friedan, The Feminine Mystique (New York: Dell
Publishing Co., Inc., 1963), p. 15
14
pill, culminated in the woman as person revoltion of the 1960s.
This liberated woman derived unexpected benefits from
the civil rights movement. The drive for school desegregation
instigated a major reevaluation of children's learning patterns,
which would alter learning concepts for women and lead to the
realization that social expectations were often self fulfilling
prophecies .
Even as Betty Friedan was writing, more and more women
were entering the labor force to find that satisfying career, and
the composition of that labor force was undergoing a funamental
change - it was composed of married women with children. In
1948, mothers of preschool children made up 10% of all women
workers; by 1974 1 out of every 3 mothers of preschoolers were at
12
work.
Other factors, such as an all time low of 1.8 children
13
per family, soaring divorce rates and revision of divorce laws
encouraged women
'
s headlong rush into the world of work. "Even
infants were increasingly likely to have working mothers. As of
1985 nearly half of all women. . .who had a child in the
14
preceeding 12 months were in the labor
force."
When we consider that in 1890 a tiny minority of 4.6% of
12
Rothman, Woman's Proper Place, p. 229
13
Ibid., p. 249
14
Sara E. Rix, ed., The American Woman 1987-88, A Report
in-Depth (New York: W.W. Norton and Co. 1987, p. 281
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15
married women worked in the labor force compared to a majority
16
of 56.1% in 1987 with all indications that this growth trend
will continue, we realize that we must maximize woman's ability
to participate fully in her work and fulfill her potential to be
a healthy, independent and responsible contributor to society
well past the menopausal age.
Consistent with these goals, the woman of today must
reformulate her relationship with her health care professional to
enter into an equal partnership, keep her own organized set of
personal medical records (as there may be no all inclusive
central file on her in this age of mobility and specialists), and
take responsibility for keeping current on all routine tests such
as pap smears and mammograms. All this will enable her and her
clinician to search out the best health care plan for her as an
individual, with the long term goal of preventing disability or
any other roadblock to vigorous well being now and in the future.
15
U.S. Bureau of the Census, Historical Statistics of the United
States, Colonial Times to 1 970 . Bicentennial Edition,
Washington, D.C., 1975, Part 1, p. 133
16
U.S. Bureau of the Census, Statistical Abstract of the United
States: 1988 (108th Edition) Washington, D.C., 1987, p. 373
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Osteoporosis
Menopause is a natural event, but doctors in the United
States developed, and some still perpetuate, the medical myth
that menopausal women suffer a crisis of a "deficiency disease"
for which treatment is needed.^
The medical infirmities resulting from estrogen
deprivation take a high toll among postmenopausal women. Nearly
200,000 hip fractures occur annually in this group, resulting in
15,000 deaths and a high morbidity rate.18
These are but two of the many divergent opinions offered to
us by experts in various health related fields. In conjunction
with our role of informed consumers, we need to explore the
nature of estrogen and progesterone loss and how it will affect
us in the years ahead.
The word
"menopause"
actually refers to a specific event --
the last menstrual period.
"Perimenopause"
refers to the
transitional time before and shortly after this event when
ovarian function and its hormone production is declining. The
ovary, with its components, primordial follicles and interstitial
tissue, undergoes gradual loss of the follicles, which are the
usual source of estrogen and progesterone, and gain of
interstitial cells, which are a probable source of androgens.
From a level of about half a million ovarian follicles in
17
Paula Brown Doress, Diana Laskin Siegal and the Midlife and
Older Women Book Project, Ourselves, Growing Older (New York:
Simon and Schuster, Inc., 1987), p. 116
18
Herbert J. Buchsbaum, ed., The Menopause, Clinical Perspectives
in Obstrectrics and Gynecology (New York: Springer-Verlog , 1983)
p. xiii
childhood, the number of follicles declines until there are few
19
remaining at menopause.
Before menopause, the major estrogenic hormone secreted by
the ovaries, estradiol, is released at a rate of 0.05 to 0.3 mg
per day into the systemic circulation. After menopause, the rate
of estradiol secretion (produced, not by the ovaries, but from
20
estrone, in adipose tissue) drops to 0.005 to 0.02 mg per day.
Since estrogen receptors have been identified in many tissues of
the body, including hypothalamus, endometrium, and vaginal
epithelium, these tissues will be directly affected by the
presence or absence of steroid hormones. Although no receptors
have been found in osseous tissue, the loss of estrogen has a
21
very definite effect on bone resorption.
Bone remodeling, the cycle of resorption and formation of
trabecular and cortical bone, is maintained in delicate balance.
Until early adulthood both males and females produce more new
bone tissue at a higher rate than is broken down. Bone mass
reaches its peak at about age 30 to 35. For women after either
19
Stuart Campbell, ed. , The Management of the Menopause and
Postmenopausal Years (Maryland: The University Park Press,
1976) , p. 15
20
K. C. Nichols, L. Schenkel and H. Benson, "1 7B-Estradiol for
postmenopausal Estrogen Replacement Therapy", Obstetrics and
Gynecology Survey, 39 (1984) p. 230-45
21
Wulf H. Utian, M.D., Ph.D., "Overview on Menopause", American
Journal of Obstretics and Gynecology, 156 No.s, (May, 1987), p,
1283
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natural or surgical menopause, trabecular bone may be lost at the
rate of 5% annually, but then levels off at about age 65. By the
time she is 80, a woman will have lost about half her trabecular
bone, a man only 14%. At menopause the rate of cortical bone
depletion increases somewhat, but does not reach a plateau at age
22
65. Cortical bone loss continues for the rest of life.
Osteoporosis is the consequence of bone resorption
progressing at a faster rate than new formation, but that bone is
essentially normal - there is just less of it. Scientists
usually classify osteoporosis into two major syndromes: type I,
postmenopausal osteoporosis and type II, age related bone loss
that can affect both men and women.
Bone loss is most severe 5 to 6 years after menopause, and
the more porous trabecular bone succumbs before the dense
cortical bone. Thus, bones rich in trabecular bone and/or
responsible for weight bearing are prime targets for fracture.
The vertebrae, which are composed of 65% trabecular and 35%
cortical bone are often the first to show signs of osteoporosis.
The affected vertebrae, usually between the midthoracic and upper
lumber segments, become biconcave, then collapse to form wedge
fractures. The posterior vertebral height is usually maintained
while the anterior portion is crushed. If several collapse,
many vertebrae may compress together and cause the rib cage
to tilt downward to produce kyphosis, or "dowager's
22
Bruce Ettinger, M.D., "Overview of the efficacy of hormonal
replacement therapy", American Journal of Obstetrics and
Gynecology, 156 No. 5, (May, 1987), p. 1300
1 9
hump."
Eventually a woman can lose up to 8" of height.
Vertebral fractures usually begin at about age 60. One half of
all 65 year old women have detectable wedging of one or more
23
vertebrae.
Wrist fractures of the distal radius (sometimes called
Colle's fractures) are increasingly common in women over age 50,
24
occurring 10 times more often in women than men.
Hip fractures are the most disabling and life
threatening consequence of osteoporosis. The over 75 age woman
(one of the fastest growing segments of our society) is more
likely to sustain this injury because the upper femur contains a
relatively large amount of cortical bone. Fewer than half of all
women who fracture a hip regain normal function. 15% die shortly
after injury and nearly 30% die within a year, not from the
fracture itself, but from complications of bed rest such as
25
pneumonia and thrombosis. Last year in the United States, 6
billion dollars were spent on the treatment of hip fractures
26
alone. Thus osteoporosis, the must common disorder of the
skeleton, is the most serious consequence of menopause.
23
Frederick S. Kaplan, M.D., "Osteoporosis", Clinical Symposia,
39, No. 1 (1987), p. 40
24
Morris Notelovitz, M.D., Ph.D. and Marsha Ware, Stand Tall
(Florida: Triad Publishing Co., Inc., 1982) p. 35
25
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If no estrogen receptors have been identified in osseous
tissue, how then does lack of estrogens cause osteoporosis?
Almost all of the body's calcium is found in the skeleton, but
the small amount remaining is essential for many other
operations, such as muscle contraction, blood clotting, and brain
function. An elaborate regulating system allows for calcium
blood level control. Vitamin D, parathyroid hormone (PTH), and
calcitonin are primarily involved in this mechanism. Among other
things, vitamin D increases the absorption of calcium in the
intestines. High levels of estrogens stimulate the synthesis of
vitamin D and increase this absorption in the intestines. One of
the functions of PTH is stimulation of osteoclastic bone
resorption to release stored calcium into the bloodstream.
Estrogens act as inhibitors to decrease the responsiveness of
bone to PTH. At this point, researchers seem to disagree about
whether PTH production decreases or increases after menopause,
but regardless, when estrogen levels fall, bone becomes
vulnerable to even relatively low levels of PTH, and bone
breakdown accelerates without the mitigating effects of estrogen.
Calcitonin, a hormone mainly released by the thyroid, directly
inhibits the activity of osteoclasts, and is stimuated by
estrogens. More studies need to be done on calcitonin, but we do
know that it decreases with age, and women with osteoporosis have
27
less of it than women with normal bone.
27
Notelovitz, Stand Tall, p. 44-46
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Plain radiography is the least sensitive method for
assessing bone density. 30% of bone mass must be lost for
28
evidence to show up on X ray. Years of routine dental X rays may
be of value for showing some changes consistent with bone mineral
loss. Blood and urine tests reflecting the loss of calcium and
hydroxyproline may also be helpful in establishing general
29
increase in bone resorption after menopause.
New assessment methods such as single-photon
absorptiometry (SPA), which compares the bone mineral content of
the patient's radius (95% cortical bone) with the bone mineral
content from a standard sex and age graph, and dual-photon
absorptiometry (DPA), which directly measures mineral content of
hip and the first through fourth lumber vertebrae (65% trabecular
bone), are much more sensitive to bone loss than plain X ray.
Quantitative CT scanning, which obtains a cross sectional view of
the vertebral body is an accurate indicator of osteoporotic
change. Obviously, DPA and CT scanning are more valuable tools
30
than SPA for evaluating postmenopausal osteoporosis.
Hopefully in the near future lower cost, greater
availability and lower radiation dosage will make these
techniques as routine as mammography has become today to provide
initial screening and long term follow-up of patients.
28
Kaplan, M.D., Clinical Symposia, p. 23
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Penny Wise Budoff , M.D. , No More Hot Flashes and Other Good
News (New York: Warner Books, Inc., 1983), p. 56
30
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It is beyond the scope of this paper to examine and
advise therapies for the prevention and control of postmenopausal
osteoporosis. At this time, although replacement estrogen is
clearly an effective bone loss treatment, contraindications and
future implications make this therapeutic strategy a highly
individual decision to be made after much investigation and
deliberation by the patient-doctor partnership.
However, certain osteoporosis risk factors have been
defined as guidelines for all women today:
. Caucasian or oriental background--Black women, with
their heavier bone mass, rarely develop osteoporosis
. Fair skin, light eyes and hair--Bone mass seems to be
directly related to amount of skin pigment
. Slender build--Women weighing under 120 pounds
. History of cigarette smoking and alcohol intake
. Never pregnant
. Never taken birth control pills
. Little weight bearing exercise
. History of taking steroids
. Early menopause, either natural or surgical
31
. Diet--Low calcium consumption.
Diet seems to be one of the most important factors in
preventing postmenopausal osteoporosis. The best guard against
this bone thinning disease is to take steps to build the greatest
possible bone mass early in life. Many young girls are at
31
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greater risk than even before for future osteoporosis because
they are chronic dieters. Johns Hopkins studies on bone mineral
density of young women in their twenties have shown decreases of
1 0 to 20% below normal density for that age, which will give them
32
a head start on osteoporosis when they enter menopause.
Thus calcium may have its greatest effect at an age
when a woman is least likely to be compliant with calcium
supplementation--that is, during the stage of bone growth and the
early adult years, when most people are not particularly
concerned about a disorder that may not affect them until they
are 65 to 75 years old. ^3
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Target Tissue Response to Hormone Loss
The menopause has a significant complicating factor in
that the aging process must also be considered when evaluating
the effect of estrogens on host tissues Aging begins at the
moment of conception and continues throughout life. however, the
aging process is usually referred to [as] the period of life in
which our bodies can no longer maintain the equlibrium and
literally begin to "wear out."34
Since a woman faces menopause at a point in her life
when she must also face the incidence of degenerative disease as
well as changing family situations, it is important to try to
differentiate between which derangements are due to aging and
which are clearly the result of steroid hormone loss. Since
estrogen receptors have been identified in many tissues such as
hypothalamus, vaginal epithelium and uterine endometrium, these
tissues are named target tissues. We can document their response
to the presence or absence of steriod homones by structure and
35
function alternation. "Target tissues are defined as tissues
characterized by the presence of highly specific protein receptor
molecules within the cells that are able to bind firmly to the
36
specific circulating
steroid."
"Estrogen receptors are found in the cytoplasm of
estrogen sensitive tissues and function by selective high
34
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affinity binding of steroid hormones to begin this process of
37
transforming molecular events into psysiologic responses.
"
(underlining mine)
The vaginal epethelium is highly responsive to estrogen
depletion. Premenopausal vaginal epithelium contains approximately
30 cell layers. After menopause there is a failure of production of
glycogen containing superficial cells and epithelium may thin to
as few as 6 fragile cells deep as epithelial maturation decreases.
Vaginal pH increases to a range of between 6.0 and 8.0 which
tends to allow unusual bacteria to replace the normal bacteria
present. The vagina also becomes narrower, shorter, and bereft
38
of rugae. The estrogen deprived vagina can easily become
irritated and bleed, a condition known as atrophic vaginitis.
The distal urethra is affected by the same changes as
those .of the vagina. This is reasonable because embryologically ,
the lower urinary tract and reproductive tract have a similar
39
origin. When estrogen deficiency converts the distal urethra to
an inelastic, easily inflamed tube--a condition called atrophic
urethritis, stricture formation may develop. Estrogen receptors
have been identified in the urethra and in the trigone of the
37
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bladder. The bladder's transitional epithelium also exhibits the
40
same response to ovarian hormones as the vaginal epithelium.
The postmenopausal cervix shows epithelial atrophy with
a flattened superficial, epithelial layer. The endocervical
glandular tissue becomes less active and less and less mucus is
produced. The atrophic changes resulting from estrogen depletion
also cause a predominance of parabasal cells, and the cervix
shrinks so that the external opening is nearly flush with the
41
shortened vaginal walls.
The body of the uterus responds to estrogen loss by
becoming smaller and the walls thinner. Uterine weight can go
from the normal 120 grams before menopause to as little as 25 to
42
30 grams in advanced age. Both estrogen and progesterone
receptors are present in the uterine endometrium, and estrogen
depletion affects both the endometrium and the myometrium layers.
The columnar epthelium of the endometrial glands flattens to
cuboidal epithelium and there is little secretion. These glands
begin to intermingle with the underlying muscular fibers. The
myometrial fibers atrophy and the smooth muscle takes on a more
43
cellular appearance.
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The fallopian tubes also contain estrogen receptors and
are subject to the same changes as the uterus--epithelial and
44
muscular atrophy.
The inexorable process of atrophy continues when we
discuss another target tissue for estrogen and progesterone
stimulation--the breast. The breast undergoes cyclic changes
during the reproductive years. Estrogen, among other hormones,
determines duct development, while progesterone influences the
glandular proliferation and fluid retention which occurs during
45
the second half of the menstrual cycle. After menopause, the
glandular substance of the breast atrophies, and adipose tissue
tends to be replaced by fibrous tissue. "indeed, atrophy of the
breasts becomes obvious as soon as six months after removal of
46
functional ovaries from premenopausal women." The skin of the
breasts atrophies at a different rate than the tissues underneath,
47
so the breasts develop a flattened appearance.
Certainly, estrogen -receptors have been identified in
skin, but considering every major body organ, skin becomes the
best example of the difficulties apparent in differentiating
44
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specific hormonal target tissue responses from general aging and
48
environmental factors, such as sun exposure.
Estrogens have been found to be actively bound and
metabolized in all skin components. The epidermis becomes
thinner after menopause. There is also a progressive decrease in
scalp and body hair follicles. Sebaceous and sweat gland
function becomes reduced. These factors result in dry, easily
traumatized skin. The dermis also becomes thinner, with less
49
resilience and pliability of the skin. Skin pigmentation and
50
hypopigmentation may also be hormone related. Alteration of
functions such as degree of water retention, number of mitoses,
extent of perfusion and carbohydrate metabolism all lead to the
fact that postmenopausal hormone skin changes contribute to skin
aging and add to its effect.
48
Utian, M.D., Ph.D., Menopause in Modern Perspective, p. 56
49
Ibid.
50
Buchsbaum, ed. , The Menopause, p. 19
29
...in a woman with normal ovulatory menses the
hormones and the autonomic hypothalamic center functions. . .are at
equilibrium to form a functional entity. As soon as the
menstrual pattern begins to deviate from the norm, a disturbance
of endocrine function may be expected to exist. This will be
most pronounced after cessation of the menses but in most cases
nature will eventually restore a balance between the two
functional systems..."51
During a woman's reproductive years, pituitary
gonadotropin production and release is controlled by two centers
in the hypothalamus. The tonic center controls production of
follicle stimulating hormone (FSH) and luteinizing hormone (LH),
while the cyclic center controls release of these hormones. The
centers are influenced by the ovarian hormones estradiol, estrone
and pregesterone. Depending on how these steroid hormones occupy
receptor sites in the hypothalamus dictates positive or negative
feedback. This will be shown as either an increase or decrease
52
in gonadotropin releasing hormone (GnRH) production.
At the time of menopause, this delicate mechanism
changes, but the basic cycle is still in effect. After menopause
53
however, this altered continuity disappears.
Even as early as 10 years before menopause, a gradual
increase in plasma levels of FSH can be detected. Later, there
is a concurrent increase in plasma LH levels. These changes are
51
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probably brought about by small decreases in estradiol
production. Several theories have been proposed, but another
possible explanation for the premenopausal increase in FSH
production is the possibility that the ovaries respond less and
less to gonadotropin stimulation. After menopause, plasma levels
of both FSH and LH are quite high. Compared to the premenopausal
state, FSH levels can be 14 times as high and LH levels 3 times
as high. Both these gonadotropins reach their highest level
54
about 3 years after menopause.
When interviewing postmenopausal women, the author
found that hot flashes (or flushes) were the most common
complaint these women reported. Since most women in this age
group today are employed outside the home, there is no
opportunity to cope during working hours by a quick shower and
change of clothes--strategies their nonworking counterparts might
use. Studies have shown that as many as 85% of women who go
through menopause experience hot flashes, and as many as 45%
55
still have hot flashes 5 to 1 0 years later.
As mentioned earlier, receptors for both estrogens and
progestins are found within the anterior hypothalamus. It is now
clear that hot flashes occur together with pulsatile release of
LH. The pathogenesis of a hot flash seems to be that the
anterior hypothalamus responds to lack of estrogens with
54
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pulsatile release of GnRH, causing pulsatile release of LH.
Thermoregulatory centers, also located in the anterior
hypothalamus are affected by the pulsatile GnRH and LH, and reset
the central body thermostat downward to lower temperature. The
body then adjusts to this new low set point by activating means
of heat dissipation such as blood vessel dilation and
56
perspiration--the hot flash.
Depression, irritability, insomnia, anxiety, and
decreased recent memory are all common menopausal complaints--
part of the menopausal syndrome.
Although estrogen replacement therapy has been shown to
be helpful in alleviating these symptoms in many women, there is
a great deal of controversy about this subject. In The
Menopause, edited by Buchsbaum, two different hypotheses are
proposed by the same researcher. In her chapter "The
Climacteric,"
she states that "aging and decreased estrogen
levels may alter dopamine-norepinephrine metabolism in the brain
sufficiently to result in an instability of the autonomic nervous
57
system."She also mentions the role of prostaglandins, which
are present in high concentrations in the hypothalamus, with the
speculation that norepinephrine or prostaglandin could produce
vasospasm and result in the menopausal irritability, depression,
and memory loss. She further relates that it is difficult to
56
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distinguish between hormone deprivation and the normal aging
58
process.
In another chapter, "Estrogen Replacement Therapy," the
same writer states that mental status does improve with ERT, but
it does so indirectly, by removing the irritants of night sweats
and insomnia, and the fact that estrogens do change sleep
patterns by shortening the time required to fall asleep and
59
increasing the length of REM sleep.
In her book, No More Hot Flashes , Dr. Budoff discusses
a study by M. Aylward in which ERT lifted menopausal depression,
possibly by increasing the availability of free tryptophan, which
60
is converted to other substances utilized by the brain. In
Management of the Menopause and Postmenopausal Years , Jaszmann
also mentions that in his studies estrogen also increased the
61
level of free tryptophan.
Research into steroid hormone influence on brain cells
continues. Studies delineating the identification and importance
of neurons that concentrate estradiol in parts of the brain such
as the medial preoptic area, medial nucleus of the amygdala, and
58
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ventromedial and arcuate nuclei of the hypothalamus--the most
dense collections of estrogen concentrating cells, have been
carried out on fish, birds, reptiles and mammals, primarily
62
rodents. Regions of the hypothalamus and limbic system just
mentioned have long been known to project into the midbrain, but
until recently it has not been known exactly which cell bodies
63
sent axons to particular midbrain regions.
The brain has been found to contain receptors for
all types of steroid hormones. These receptor sites, as
mentioned before, are not distributed evenly, but occupy specific
areas in the brain. Because of this, research into these
64
particular areas of the brain is particularly valuable and may
answer many questions about estrogen loss related depression at
menopause and hypotheses about sex differences in hormone action
65
on the brain.
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Cardiovascular Disease and Hormone Loss
"Men were designed for short, nasty, brutal
lives,"
says
Dr. Estelle Ramey of Georgetown University Medical
School, "Women are designed for long, miserable
ones."
One explanation lies in evolution. Nature gives females
a hormonal edge during the reproductive years, when more
women than men are needed to perpetuate the species.
Estrogen helps a woman's liver prevent the accumulation
of cholesterol and makes her blood vessels more
resilient to stress. Men are designed to protect women:
the possibility for injury may be one reason his blood
clots faster than hers - and why he has a greater risk
of an early heart attack. But the female edge
disappears with menopause. When estrogen production
stops, she becomes prone to heart disease and the
crippling wasting of bones known as osteoporosis. 66
Ischemic heart disease is the number one cause of death
67
for both men and women in the United States. Although breast
cancer claimed the lives of 36,000 women in 1982, cardiovascular
disease was the cause of death for 355,000 women in this country.
For some time it has been observed that estrogens exert
a protective effect on lipid and lipoprotein metabolism.
Premature menopause has been associated with increased incidence
and early development of ischemic heart disease. The rise in
plasma cholesterol occurs after either surgical or natural
66
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menopause.
"The plasma concentrations of certain cholesterol
carriers, such as high-density lipoprotein (HDL) cholesterol and
low-density lipoprotein (LDL) cholesterol are strong and
70
consistent predictors of the risk of ischemic heart disease."
High levels of HDL seem to be protective, while high levels of
71
LDL appear to increase heart disease risk.
However, most research on heart diseasse has been
conducted on men, and several studies utlizing women subjects
have had seemingly contradictory findings, so a definitive
conclusion has certainly not been reached.
One large piece of research, the Framingham Heart Study
examined "...the effect of estrogen use on morbididy from
cardiovascular disease in 1234 postmenopausal women, aged 50 to
72
83 years...", and concluded that "No benefits from estrogen use
were observed in the study group; in particular, mortality from
all causes and from cardiovascular disease did not differ for
69
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estrogen users and non
users."
After this study's publication in The New England
Journal of Medicine, a flurry of letters appeared in the same
journal rebutting the study's conclusion because it did not
conform to the rigorous criteria of a double blind randomized
trial and claiming it was flawed and could not be definitive
about the effects of estrogen use on cariovascular disease. In
fact there was a barrage of letters written to the editor, each
with different explanations and conclusions about the Framingham
and other related studies on estrogen and cardiovascular disease.
In the Journal of the American Medical Association' s
"Medical News and Perspectives," debate continued as Lila E.
Nachtigall, M.D., associate professor of obstetrics and
gynecology at New York University School of Medicine predicted
that "the risk of cardiovascular disease will soon become an
74
indication for estrogen relacement
therapy."
However, in the
same article, Robert Schlant, M.D. , Chairman of the American
Heart Association's Clinical Cardiology committee was quoted as
stating that "we do not have any clinical data from a good,
controlled group to say that [a long term] homonal replacement
therapy is of definate value, [for the reduction of
73
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cardiovascular disease]
Estrogen has been found to increase levels of the
"good"
HDL and decrease levels of the "bad" LDL, but the problem
is that progestins, normally given along with estrogen in E.R.T. ,
have been shown to lower HDL levels by 15%, which is equivalent
76
to the increase brought on by the estrogen.
The ratio of coronary artery disease deaths in men and
women differs dramatically with advancing age - at age 45 the
77
ratio is 8 to 1 , while at age 85 that ratio equalizes to 1 to 1 .
There are so many factors that have a major impact on the
incidence of coronary deaths, such as heredity, smoking, diet,
hypertension and diabetes, that it is difficult to delineate the
role of estrogen as a definite factor in cardiovascular disease.
Cardiovascular change is extremely difficult to separate from the
aging process, since arteriosclerosis follows along with aging,
so the protective nature of estrogen on coronary artery disease
78
remains complicated and controversial.
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The cause-and-effect relationship between
menopausal hormonal changes and target tissue
effects is not always apparent because
menopause is a syndrome that occurs over time
At the beginning of the climacteric the
occurrence of hot flushes, and symptoms of
vaginal atrophy occur relatively close
together. Later, other signs appear such as
bladder symptoms and endocrine-related apsects
of heart disease and osteoporosis. Thus the
time discrepancy obscures the cause-and-effect
relationship, as may the general aging process
and even psychosocial factors. 79
And so we must succeed in separating age from illness if
we are going to meet the challenge of our future years. It is
not going to be enough just to survive - our goal must not be to
extend old age, but to lengthen those productive middle years so
that we remain valuable contributors to our families and society,
and prevent ourselves from becomming emotional and financial
80
burdens to our younger relatives.
This is indeed a tall order, but we as a population have
made a start by responding to the increasing body of evidence
elucidating the fact that the majority of our disabling diseases
can be prevented. Eliminating smoking, exercising more and
paying attention to diet are just a few examples of the results
of our growing awareness of the effectiveness of prevention.
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Tough choices await us along the way. Not only may we
have to face the decision whether to use some of the advanced
life support technology for ourselves or relatives, but we also
need to be aware of what therapies exist at which hospitals -
before an emergency develops. One example of this was
reported in June, 1988. The two largest hospitals in
Rochester, New York are divided on the type of thrombolytic drug
therapy to use on patients brought to the hospital immediately
after a heart attack. Rochester General Hospital uses tissue
plasminogen activator (TPA), while streptokinase is the drug of
81
the choice for Strong Memorial Hospital. This debate has
ramifications for the health care consumer, and is just one of
the many factors involved in selecting a hospital.
The reasonable goal of reaching that life milestone,
menopause, is only a fairly recent expectation, since from
10,000 B.C. to 1640 A.D. most women could expect to live about 32
82
years. But it is now 1988, and we look to a future where we
may expect to live a full third or more of our lives
postmenopausally. Now as never before, the woman of today needs
to be extremely well informed to make intellegent choices which
may well affect how productive and meaningful that postmenopausal
third of her life will become.
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Although estrogen replacement therapy (ERT) is extremely
effective in alleviating symptoms of early menopause such as hot
flashes, and in preventing long term effects, such as
osteoporosis, obviously a blanket endorsement of ERT should not
be considered. Whatever therapy, if any, the patient and
physician decide on must be carefully researched and
individualized. One primary consideration is the fact that after
menopause estrogen is still being converted in the adrenal glands
and adipose tissue, and the amount can vary greatly from woman
83
to woman. Normally, circulating estrogen levels are decreased
in most postmenopausal women, but in some obese postmenopausal
women estrogen levels may be higher than those found in other
84
premenopausal females.
There are many obvious contraindications for ERT, but
there are also some subtle implications of estrogen replacement
or augmentation. Although ERT, including the addition of a
progestin, has been found in most studies not to increase the
risk of endometrial or breast cancer, and in some studies has
85
actually been found to decrease those cancer risks, one must
still consider that ERT may accelerate preexisting breast cancer,
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especially if that cancer is the type which demonstrates estrogen
86
receptors. Since "a single cancer cell divides on average,
only once every hundred days, at that rate the aberrate cell
87
may take eight years to form a pea-sized lump," a tiny cancer
cell group may not be detected by mammography, but still exist in
the breast. The incidence of breast cancer has been found to
increase throughout a woman's lifespan, unlike cervical,
88
endometrial or ovarian cancers, so this situation is a serious
consideration in the decision to use supplemental estrogen.
This one example of the ramifications of choosing a
therapy to prevent, rather than cure must, in the final analysis
be the informed patient's responsibility. A recent letter to the
editor of the New York Times Magazine speaks eloquently about
this perspective:
Medicine is now an interactive process
between doctor and patient. The physician has
the responsibility to provide the patient with
a cogent explanation of his treatment and
reasonable options whenever invasive care is
necessary- The patient has the responsibility
to integrate the treatment options and make a
final, informed decision. 9
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The importance of advanced decision making and the whole
topic of prevention is brought into stark focus by a trip to a
downtown department store. (Never mind a nursing home!) There
we can see the plight of the little old lady precariously making
her way with the aid of a cane, nearly bent over on her fragile
bones. In the suburbs and the office one is only used to seeing
the healthy young and middle aged, so a trip to the center city
highlights the plight of these frail beings.
Jane Gould, director of the New York State Office of the
Aging speaks of the fastest growing population group in this
country - the over 85 age set, and she worries who will
"
meet
the needs of those with acute or chronic illnesses. Who will
90
take care of these
people?"
Studies have shown that age and illness can be
separated, and that chronological age alone is not a good index
of our capabilities. Therefore, with better prevention of
chronic disease and earlier detection of acute illness, the answer
may well be that we, the future elderly, will be taking care of
ourselves .
90
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